The news directly pertains to Morgan Stanley as its price target has been lowered by Oppenheimer. However, the Outperform rating is maintained which indicates that the analyst still expects the stock to do better than the market average. This could have a neutral impact on the stock as the lower price target might discourage some investors, but the maintained Outperform rating could also attract others.